Form 4: Genpact SVP & Chief Legal Officer Sells Shares
Insider Transaction Report
Genpact's SVP & Chief Legal Officer, Heather White, reported multiple transactions involving the exercise of stock options and subsequent sale of common shares in November 2025.
Summary
- Heather White, SVP & Chief Legal Officer of Genpact LTD, engaged in several transactions involving the company's common shares and employee stock options.
- On November 11, 2025, 1,039 common shares were sold at a price of $44.02 per share.
- On November 12, 2025, 4,351 employee stock options were exercised at a price of $27.70 per share, followed by the sale of 4,351 common shares at $45.74 per share.
- On November 13, 2025, 45,703 employee stock options were exercised at a price of $27.70 per share, followed by the sale of 45,703 common shares at $45.74 per share.
- The options exercised on November 12 and 13, 2025, had an expiration date of January 9, 2029, and vested 50% on January 10, 2022, and 50% on January 10, 2024.
- Following all reported transactions, the reporting person beneficially owns 50,569 common shares directly.
- This beneficial ownership includes 560 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP), with 30 shares acquired since the previous Form 4 filing on March 13, 2025.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions involving the exercise of vested stock options and subsequent sale of shares. This is a common practice for executives managing personal finances and equity compensation, and does not inherently indicate a strong positive or negative sentiment towards the company's future prospects.
Positives
- The exercise of stock options at a strike price of $27.70, significantly below the sale prices of $44.02 and $45.74, indicates a profitable realization of equity compensation for the reporting person.
- The transactions demonstrate the value of the company's equity compensation program for its executives.
Negatives
- The sale of a substantial number of shares by a senior officer, totaling 51,093 shares across the reported dates, could be perceived by some investors as a reduction in insider exposure to the company's stock.
Stakeholder Impact
- Shareholders: The transactions represent a routine insider sale following option exercise, which is common for personal financial planning and diversification. It does not typically signal a significant change in company outlook, but a large sale by a key officer is noted.
Key Dates
| Date | Description |
|---|---|
| 01/10/2022 | 50% of employee stock options vested. |
| 01/10/2024 | Remaining 50% of employee stock options vested. |
| 03/13/2025 | Date of the reporting person's previous Form 4 filing. |
| 11/11/2025 | Sale of 1,039 common shares. |
| 11/12/2025 | Exercise of 4,351 employee stock options and subsequent sale of 4,351 common shares. |
| 11/13/2025 | Exercise of 45,703 employee stock options and subsequent sale of 45,703 common shares. |
| 01/09/2029 | Expiration date of the exercised employee stock options. |
Keywords
Genpact, G, Form 4, Insider Trading, Stock Options, Share Sale, Beneficial Ownership, Heather White, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.